Stage III colon cancer showed low budding in 143 (Bd1; 69.8%), intermediate budding in 48 (Bd2; 28.4%), and high budding in 14 (Bd3; 6.8%) cases. This evidence concerns the gene DEFB1 and malignant colon neoplasm.